Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods-Reference-Cited by-同舟云学术

Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods

Published:1997-09 Issue:3 Volume:45 Page:241-249
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Molino A.,Micciolo R.,Turazza M.,Bonetti F.,Piubello Q.,Corgnati A.,Sperotto L.,Recaldin E.,Spagnolli R.,Manfrin E.,Bonetti A.,Nortilli R.,Pollini G.P.,Modena S.,Cetto G.L.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.springerlink.com/index/pdf/10.1023/A:1005769925670

Reference41 articles.

1. Wollenweider-Zerargui L, Barrelet L, Wong Y et al.: The predictive value of estrogen and progesterone receptor concentrations on the clinical behavior of breast cancer in women. Clinical correlations in 547 patients. Cancer 57: 1171–1180, 1988

2. Williams MR, Todd JH, Ellis IO et al.: Oestrogen receptors in primary and advanced breast cancer. An eight-year review of 704 cases. Br J Cancer 55: 67–73, 1987

3. Alexieva-Figusch J, Van Putten WL, Blankestein M: The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer. Cancer 61: 758–768, 1988

4. Clark GM, McGuire WL: Steroid receptors and other prognostic factors in primary breast cancer. Semin Oncol 15(supp.): 20–25, 1988

5. Molino A, Turazza M, Bonetti A et al.: Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis. Oncology 49: 82–88, 1992

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit;ACTA ONCOL;2024

2. Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit;Acta Oncologica;2024-04-08

3. Prediction of Tamoxifen Benefit in Premenopausal Breast Cancer Patients Evaluated by Three Methods for Determination of Hormone Receptor Status;2023-10-02

4. Current Standard Clinical Predictive Markers;A Comprehensive Guide to Core Needle Biopsies of the Breast;2022

5. Estrogen- and estrogen receptor (ER)-mediated cisplatin chemoresistance in cancer;Life Sciences;2021-12